Abstract

Xenome's Xen2174 Enters Human Clinical Trials. CyGenics Renewed NIH Contract on T Cell Technology. Novogen's Cardiovascular Drug Enters Human Clinical Trial. Rockeby's CANDIA5 Completed FDA 510K Trial. AustCancer's Revisys Supplements Coming to Singapore. Life Therapeutics and UK BioProducts in Negotiation for Anti-D Product. CSL To Distribute Acrux's MDTS for Female Testosterone Treatment. Indian Biotech Industry Needs More Mature Funding. Ocimum Licensed Biotracker to ARIUS Research. Lupin to Shut Down Its South African Subsidiary. Sinomem Ties Up with Local University in Membrane Work. SciGen to Market SciLin in India.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.